Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
28
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
09 Feb 2018 06:22
KOSDAQ 150 Rebalancing & Celltrion Short Selling During Feb 7-8
The KRX officially said on Feb 7 that Celltrion Inc (068270 KS) would be listed on the KOSPI on Feb 9. This means there would be a massive index...
Sanghyun Park
Follow
485 Views
Share
bullish
•
Celltrion Inc
•
04 Feb 2018 00:10
Last Week in Event SPACE - Astellas, Celltrion, Renesas, AWE, Viva, Kushikatsu
Last week, Astellas Pharma Inc (4503 JP)'s latest buyback may impact the stock; KOSDAQ 150 names expected to benefit as Celltrion Inc (068270 KS)...
David Blennerhassett
Follow
417 Views
Share
bullish
•
Celltrion Inc
•
30 Jan 2018 20:45
Impact Analysis of Celltrion's KOSPI Move on KOSPI 200 and KOSDAQ 150
The KRX senior official named Lee Eun-tae had a press conference yesterday (Jan 29). He gave the major projects that the KRX is currently planning...
Sanghyun Park
Follow
596 Views
Share
bullish
•
Celltrion Inc
•
05 Jan 2018 12:28
Celltrion (068270 KS): Korean Making Biological Drugs for the West
Solid long-term sales growth, strong sales momentum, and high earnings quality relative to its sector Celltrion is one of Korea’s top exporters of...
A. Stotz Investment Research
Follow
268 Views
Share
bullish
•
Samsung Electronics Pref Shares
•
06 Nov 2017 00:54
Samsung Electronics Common-Pref Spread - Data & Situational Study
Let's do one interesting study here. In the last month (Oct 10-Nov 3), Samsung Electronics Pref Shares (005935 KS) ranked fifth in the local...
Sanghyun Park
Follow
500 Views
Share
First
Previous
132
133
134
135
136
137
138
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x